These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20664331)

  • 21. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study.
    Srinivas VS; Brooks MM; Detre KM; King SB; Jacobs AK; Johnston J; Williams DO
    Circulation; 2002 Sep; 106(13):1627-33. PubMed ID: 12270854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes.
    Siddique A; Murphy TP; Naeem SS; Siddiqui EU; Pencina KM; McEnteggart GE; Sellke FW; Dworkin LD
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):E217-E224. PubMed ID: 30467952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-pump versus off-pump coronary artery bypass graft surgery among patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Singh A; Schaff HV; Mori Brooks M; Hlatky MA; Wisniewski SR; Frye RL; Sako EY;
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):406-16. PubMed ID: 25968885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
    Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
    Dagenais GR; Lu J; Faxon DP; Bogaty P; Adler D; Fuentes F; Escobedo J; Krishnaswami A; Slater J; Frye RL;
    J Am Coll Cardiol; 2013 Feb; 61(7):702-11. PubMed ID: 23410541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.
    Giustino G; Dangas GD
    Prog Cardiovasc Dis; 2015; 58(3):306-15. PubMed ID: 26255239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group
    Am Heart J; 2008 Sep; 156(3):528-536, 536.e1-5. PubMed ID: 18760137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease.
    Tsujimoto T; Kajio H
    Sci Rep; 2019 Mar; 9(1):3502. PubMed ID: 30837527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
    Khan AA; Chung MJ; Novak E; Brown DL
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
    Ikeno F; Brooks MM; Nakagawa K; Kim MK; Kaneda H; Mitsutake Y; Vlachos HA; Schwartz L; Frye RL; Kelsey SF; Waseda K; Hlatky MA;
    J Am Coll Cardiol; 2017 Jan; 69(4):395-403. PubMed ID: 28126156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
    Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of therapies for type 2 diabetes and coronary artery disease.
    ; Frye RL; August P; Brooks MM; Hardison RM; Kelsey SF; MacGregor JM; Orchard TJ; Chaitman BR; Genuth SM; Goldberg SH; Hlatky MA; Jones TL; Molitch ME; Nesto RW; Sako EY; Sobel BE
    N Engl J Med; 2009 Jun; 360(24):2503-15. PubMed ID: 19502645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.
    Ivens K; Gradaus F; Heering P; Schoebel FC; Klein M; Schulte HD; Strauer BE; Grabensee B
    Int Urol Nephrol; 2001; 32(4):717-23. PubMed ID: 11989572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.